Crucell N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
05 jan 2006 - 08:19
Statutory name
Crucell N.V.
Title
Crucell Licenses STAR(TM) Technology to XOMA for Research Use
Comments
Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that it has signed a non-exclusive STAR™ research license agreement for the production of monoclonal antibodies and other proteins with Berkeley, California-based XOMA Ltd. (NASDAQ: XOMA).
Date last update: 18 July 2025